Cyclic AMP blocks expression of the c-sis gene in tumor cells

Oncogene Res. 1989;4(1):65-73.

Abstract

Some human tumor cell lines express the c-sis gene, the proto-oncogene of the transforming gene v-sis, and produce platelet-derived growth factor, which may contribute to carcinogenesis by autocrine or paracrine mechanisms. Here we demonstrate that c-sis expression in some human glioma and osteosarcoma cell lines can be blocked by agents that increase cellular cyclic adenosine monophosphate (cAMP). Forskolin, 8-bromocyclic AMP, cholera toxin, and prostaglandin E1 reduced c-sis mRNA in these cells by up to 90%. c-sis transcription rates were reduced by agents that increase cAMP; the stability of c-sis mRNA was unaffected. The possible therapeutic value of blocking the expression of tumor growth factor genes pharmacologically warrants further study.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Colforsin / pharmacology
  • Cyclic AMP / physiology*
  • Gene Expression Regulation*
  • Humans
  • Platelet-Derived Growth Factor / genetics*
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins c-sis
  • Proto-Oncogenes*
  • Receptors, Cell Surface / analysis
  • Receptors, Platelet-Derived Growth Factor
  • Transcription, Genetic
  • Tumor Cells, Cultured

Substances

  • MAS1 protein, human
  • Platelet-Derived Growth Factor
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-sis
  • Receptors, Cell Surface
  • Colforsin
  • Cyclic AMP
  • Receptors, Platelet-Derived Growth Factor